Metafin, a non-banking finance company (NBFC) focused on solar loans, has raised USD 10 million (approximately INR 83 crore) ...

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotech's shares closed the day nearly 3% ...

Vertex Pharmaceuticals Inc. closed 5.66% below its 52-week high of $519.88, which the company reached on November 8th.

Google's updated guidance clarifies that Google-Extended is not used as a ranking signal, nor does it affect search inclusion ...

Vertex, Inc. (NASDAQ:VERX), is not the largest company out there, but it led the NASDAQGM gainers with a relatively large price hike in the past couple of weeks. While good news for shareholders, the ...

Existing investors Prime Venture Partners and Varanium Capital participated in the Series A round, along with Northern Arc ...

Cleantech-focused NBFC Metafin has raised $10 million (around Rs 85 crore) in its Series A round led by Vertex Ventures ...

Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK ® ...

Metafin will use the newly raised funds to deepen its presence in core markets, expand into new states, and strengthen its ...

Metafin, a solar-focused NBFC, raised $10 million in Series A funding led by Vertex Ventures to scale clean energy loans, ...

You can still find attractive stocks despite all of the turbulence. Many stocks have been losers in 2025 amid the market chaos, but not Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). Shares of Warren ...